Sichuan Huiyu Pharmaceutical Co., Ltd. (SHSE: 688553)
Health Care · Pharmaceuticals · CN
CN¥12.85
+4.81% today · -10.8% 1Y
Sichuan Huiyu Pharmaceutical Co., Ltd. (SHSE: 688553) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.19B and employs 1,366 people.
Over the last twelve months the share price has lost 10.8%, trading between 9.61 and 17.33.
Tweenvest scores Sichuan Huiyu Pharmaceutical Co., Ltd. across four factors: quality 67/100, value 18/100, growth 0/100, dividend 37/100. Its strongest factor is quality.
688553 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.19B
- Revenue (TTM)
- $161.48M
- P/E
- 70.51
- EPS
- 0.18
- Dividend yield
- 1.05%
- Beta (5Y)
- 0.51
- 52-week high
- CN¥17.33
- 52-week low
- CN¥9.61
- Avg volume (3M)
- —
- Shares outstanding
- 623.76M
- Employees
- 1,366
- Next earnings
- —
About Sichuan Huiyu Pharmaceutical Co., Ltd.
Sichuan Huiyu Pharmaceutical Co., Ltd. researches, develops, produces, and sells anti-tumor injection in China and internationally. It offers injection drug products, such as pemetrexed disodium, methrotrexate, docetaxel, azacitidine, oxaliplatin, cyclophosphamide, irinotecan hydrochloride, paclitaxel, bendamustine hydrochloride, decitabine, palonosetron hydrochloride, plerixafor, levetiracetam concentrated solution, amifostine, levofolate calcium, thiotepa, fulvestrant, and milrinone drugs. The company also offers moroxydine sodium chloride, fluorouracil, sodium thiosulfate, acetylcysteine, nimodipine, nimodipine, dihydroxypropyltheophylline, cisatracurium besylate, cladribine, sodium carbosulfan, octreotide acetate, mesobamo, doxorubicin, leucovorin calcium, famotidine, etoposide, polymyxin B sulfate, melphalan hydrochloride, teicoplanin, epirubicin hydrochloride, gemcitabine hydrochloride, cytarabine, voriconazole, roxatidine acetate hydrochloride, and bortezomib drugs. Sichuan Huiyu Pharmaceutical Co., Ltd. was incorporated in 2010 and is headquartered in Neijiang, China.
- ISIN
- CNE100004ZT4
- Founded
- 2010
- Listed since
- Oct 26, 2021
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shandong Lukang Pharmaceutical Co.,Ltd.SHSE: 600789 | $1.22B | CN¥7.85 | +4.11% |
| HARBIN GLORIA PHARMACEUTICALS Co., LTDSZSE: 002437 | $1.21B | CN¥3.65 | +4.29% |
| Aurisco Pharmaceutical Co.,Ltd.SHSE: 605116 | $1.21B | CN¥20.07 | +2.40% |
| Shanghai Yizhong Pharmaceutical Co., Ltd.SHSE: 688091 | $1.20B | CN¥39.40 | -1.38% |
| LB Pharmaceuticals IncNasdaqGM: LBRX | $1.19B | $34.61 | -6.43% |
| Cronos Group Inc.TSX: CRON | $1.18B | CA$4.58 | -0.87% |
| Wanbangde Pharmaceutical Holding Group Co., Ltd.SZSE: 002082 | $1.18B | CN¥12.97 | +8.08% |
| Zhejiang Tianyu Pharmaceutical Co., Ltd.SZSE: 300702 | $1.17B | CN¥22.68 | +6.48% |
Figures last refreshed Oct 4, 2026.